Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases Podcast Por arte de portada

Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases

Drying, Durability, and Disease Control: Evolving Metrics of Anti-VEGF Success in Retinal Diseases

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Ehsan Rahimy, MD; David G. Miller, MD, Esther Kim, MD, discusses how achieving retinal drying through anti-VEGF therapies remains a critical marker of treatment success in retinal diseases like AMD and DME, while highlighting the benefits of newer agents like aflibercept 8mg and faricimab for providing better durability and sustained disease control with reduced treatment burden.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones